← Leaderboards
Batbileg Bor
Ada Forsyth Institute, Inc.
$3,264,149
Attributed
$3,466,828
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $806.9K · FY2015–25$1M$750K$500K$250K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,466,828 · 5
By mechanism
R01$2,036,972 · 1
R00$747,000 · 1
R43$304,019 · 1
K99$268,002 · 1
F32$110,835 · 1
Top collaborators
- James W Larrick1 shared
- Andrew R Mendelsohn1 shared
Most similar at Ada Forsyth Institute, Inc.
Same institution · by research overlap
- Jorge Frias-Lopez$5,962,958
- Xuesong He$7,731,091
- Mary Ellen Davey$11,091,417
- Wenyuan Shi$8,881,483
- Alexandru Movila$4,060,012
Others in their field
Top investigators on “Periodontal Diseases”
- Georgios Hajishengallis · University Of Pennsylvania$27,083,126
- Richard J Lamont · Research Inst Nationwide Children'S Hosp$23,695,709
- Salomon Amar · Boston Medical Center$18,325,608
- Steven Nmn Offenbacher · University Of North Carolina Chapel Hill$17,562,055
- Ricardo P Teles · Beth Israel Deaconess Medical Center$17,089,524
- Dana T Graves · University Of Pennsylvania$15,466,431
Research focus
Periodontal DiseasesPeriodontitisCellsOralPathogenesisInflammatoryMacrophagePathogenicitySurfaceIn VivoOral CavityBacteriaLinkInvestigationMemberGeneticLibrariesAffectIn VitroOral MicrobiomeGenomeCell SizeCharacteristicsMucous Membrane
Grant awards (13)
Impact of Saccharibacteria and their bacterial hosts in Periodontal and Inflammatory Diseases$478,087
R01 · FY2025 · DE · contact PI
Impact of Saccharibacteria and their bacterial hosts in Periodontal and Inflammatory Diseases$479,181
R01 · FY2024 · DE · contact PI
Novel therapy to prevent alveolar bone loss in severe periodontitis$304,019
R43 · FY2024 · DE
Impact of Saccharibacteria and their bacterial hosts in Periodontal and Inflammatory Diseases$521,771
R01 · FY2023 · DE · contact PI
Impact of Saccharibacteria and their bacterial hosts in Periodontal and Inflammatory Diseases$557,933
R01 · FY2022 · DE · contact PI
Molecular and pathogenic study of an oral TM7 strain, the first cultivated ultra-small bacterium$249,000
R00 · FY2022 · DE · contact PI
Molecular and pathogenic study of an oral TM7 strain, the first cultivated ultra-small bacterium$249,000
R00 · FY2021 · DE · contact PI
Molecular and pathogenic study of an oral TM7 strain, the first cultivated ultra-small bacterium$249,000
R00 · FY2020 · DE · contact PI
Molecular and pathogenic study of an oral TM7 strain, the first cultivated ultra-small bacterium$134,001
K99 · FY2019 · DE · contact PI
Molecular and pathogenic study of an oral TM7 strain, the first cultivated ultra-small bacterium$134,001
K99 · FY2018 · DE · contact PI
Phenotypic, transcriptomic and pathogenic study of the first cultivated TM7 strain$711
F32 · FY2017 · DE · contact PI
Phenotypic, transcriptomic and pathogenic study of the first cultivated TM7 strain$56,918
F32 · FY2016 · DE · contact PI
Phenotypic, transcriptomic and pathogenic study of the first cultivated TM7 strain$53,206
F32 · FY2015 · DE · contact PI